- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
Capita Healthcare Decisions supports national online healthcare service in Australia
11 June 2015 • Author: Victoria White
Capita Healthcare Decisions has won a contract with Healthdirect Australia to help people check their symptoms online and receive personalised healthcare advice.
With over 80% of Australians seeking health information online, Healthdirect Australia recognised the importance of ensuring that the information they are accessing is safe, relevant and trustworthy. In response they developed the Healthdirect Symptom Checker – an online tool which allows people to check their symptoms and receive personalised advice on what healthcare action to take next.
Healthdirect Australia chose Capita’s proven Decision Management Software (DMS) to power Symptom Checker. The DMS will allow the organisation to aggregate its own verified content and present it to consumers on www.healthdirect.gov.au through Capita’s Application Programming Interface (API). All health information in the Symptom Checker has been through a clinically governed quality assurance review.
Capita’s DMS and API have significantly reduced the time taken to populate the Symptom Checker flows with verified clinical content, and required changes and updates are simple to undertake.
Healthdirect Australia, an organisation established by the Council of Australian Governments, designs and delivers a range of innovative services to provide every Australian with 24/7 access to the trusted information and advice they need to manage their own health and health-related issues.
Capita Healthcare Decisions is a real UK export success story
Professor Anton Donker, chief information officer at Healthdirect Australia, said, “An ageing population, the growth of digital by default and patients that are often living in rural or remote locations has made online access a vital part of the way we ensure that all Australians receive good quality health advice and assessment.
“The Symptom Checker places users at the centre of decision-making by guiding them to the appropriate healthcare option based on their current symptoms, helping them find local health services, and providing links to further information about their symptoms and possible causes.”
Richard Atkins, general manager, international, for Capita Healthcare Decisions, said, “Our decision support software has been used by some of the world’s leading healthcare providers to power more than 85m patient transactions. We revolutionised access to 24 hour health support and advice here in the UK, but our systems are also now being used as far afield as Australia, Ghana and Brazil, making Capita Healthcare Decisions a real UK export success story.”
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) EUROGENTEC F.P.S. Food and Pharma Systems Srl IDBS JEOL Europe L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Metrohm Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics